12 Best Strong Buy Stocks to Invest in According to Wall Street

Page 1 of 11

In this article, we will look at the 12 Best Strong Buy Stocks to Invest in According to Wall Street.

On September 26, Peter Boockvar, chief investment officer at One Point BFG Wealth Partners, appeared on CNBC to talk about the likelihood of the Federal Reserve’s interest rate cuts, new inflation data, and more.

His take on the situation is that the problem is that the core PCE remains stuck around 3%, and it’s really “tying” the central bank’s hands. He does not anticipate aggressive rate cuts unless the labor market really deteriorates.

READ ALSO: Stocks On The Rise: 12 Best Stocks to Invest in Right Now and 12 Affordable Biotech Stocks to Invest In Now

He added that if there is going to be a reason for a pullback in the stock market, it is likely going to be the AI tech trade exhausting itself, along with the realization that we are in what he calls a “rate-tweaking cycle” instead of a “rate-cutting cycle.”

With these trends in view, let’s look at the best strong buy stocks to invest in according to Wall Street.

12 Best Strong Buy Stocks to Invest in According to Wall Street

Our Methodology

We used stock screeners and TipRanks to make a list of the best Strong Buy stocks and selected the top 12 with the highest analyst upside potential. We also added the number of hedge fund holders for each stock as of Q2 2025, sourcing the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of analyst upside potential.

Note: All data was sourced on September 26.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

12 Best Strong Buy Stocks to Invest in According to Wall Street

12. Clearwater Analytics Holdings, Inc. (NYSE:CWAN)

Analyst Upside: 74.13%

Number of Hedge Fund Holders: 51

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is one of the best strong buy stocks to invest in according to Wall Street. On September 16, William Blair analyst Dylan Becker reiterated a bullish stance on Clearwater Analytics Holdings, Inc. (NYSE:CWAN), giving it a Buy rating without assigning a price target.

The analyst based the optimistic rating on the company’s future potential and strategic positioning, stating that the recent Clearwater Connect 2025 conference exhibited Clearwater Analytics Holdings, Inc.’s (NYSE:CWAN) vision for the creation of the industry’s first unified, end-to-end platform for investment management.

The analyst expects this to address the rising complexity in asset management.

Clearwater Analytics Holdings, Inc. (NYSE:CWAN) provides web-based investment portfolio accounting, reporting, and reconciliation services. The company’s operations are divided into the United States and the Rest of the World geographical segments.

11. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Analyst Upside: 74.25%

Number of Hedge Fund Holders: 28

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best strong buy stocks to invest in according to Wall Street. On September 24, JPMorgan analyst Jessica Fye lowered the firm’s price target on Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) to $52 from $53 while keeping an Overweight rating on the shares.

The firm told investors that it updated Crinetics Pharmaceuticals, Inc.’s (NASDAQ:CRNX) model to reflect slightly higher spending assumptions.

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a clinical-stage pharmaceutical company that develops and commercializes novel therapeutics for rare endocrine diseases and endocrine-related tumors.

The company’s product candidate, CRN00808, is an oral treatment for acromegaly. It is also developing other oral treatments for neuroendocrine tumors, hyperinsulinism, and Cushing’s disease.

Page 1 of 11